Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation

por Leong, K J, Beggs, A, James, J, Morton, D G, Matthews, G M, Bach, S P
Publicado 2014

Reorganisation of Wnt-response pathways in colorectal tumorigenesis

por Caldwell, G M, Jones, C E, Soon, Y, Warrack, R, Morton, D G, Matthews, G M
Publicado 2008

The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas

por Caldwell, G M, Jones, C E, Taniere, P, Warrack, R, Soon, Y, Matthews, G M, Morton, D G
Publicado 2006

Wnt signalling in adenomas of familial adenomatous polyposis patients

por Caldwell, G M, Jones, C E, Ashley, A M, Wei, W, Hejmadi, R K, Morton, D G, Matthews, G M
Publicado 2010

Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma

por Matthews, G M, Lefebure, M, Doyle, M A, Shortt, J, Ellul, J, Chesi, M, Banks, K-M, Vidacs, E, Faulkner, D, Atadja, P, Bergsagel, P L, Johnstone, R W
Publicado 2013